HS was founded in 1980 for spreading the most innovative medical techniques and technologies for minimally invasive diagnostics and for US-guided percutaneous treatments. Today HS is a world market leader in interventional oncology, aiming at ever raising the bar of clinical excellence to the benefit of all.
In healthcare technologies, success can only be achieved through excellence.
We help building excellence day after day through advanced device design, meticulous manufacturing and utmost attention to the customers’ needs. We are in the mainstream of clinical research, together with international KOLs, always looking forward to the best solutions for patients .
Our everyday work, side by side with clinicians, medical researchers and all other stakeholders in interventional oncology, helps us to ever increase our knowledge of what it really takes to minimize pain and maximize quality of life for patients.